Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 2250 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/04
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 04/22/21
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 04/14/10
End: 04/07/15
Due: 04/07/16
Phase: N/A
Priority: Normal
Start: 04/25/05
End: 05/30/05
Due: 05/30/06
Phase: N/A
Priority: Normal
Start: -
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/07/24
End: 09/12/26
Due: 09/12/27
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
Phase: N/A
Priority: Normal
Start: 09/19/97
End: 05/13/11
Due: 05/13/12
Phase: N/A
Priority: Normal
Start: 04/16/10
End: 01/12/17
Due: 01/12/18
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 04/30/98
End: 03/31/00
Due: 03/31/01
Phase: N/A
Priority: Normal
Start: 08/27/12
End: 03/08/23
Due: 03/08/24
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 08/21/18
End: 06/14/20
Due: 06/14/21
Phase: N/A
Priority: Normal
Start: 01/05/10
End: 08/26/20
Due: 08/26/21
Phase: N/A
Priority: Normal
Start: -
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 06/02/04
End: 02/05/07
Due: 02/05/08
Phase: N/A
Priority: Normal
Start: 06/07/06
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: -
End: 06/30/98
Due: 06/30/99